A chemiluminescent catalytic antibody†

Abstract

A monoclonal antibody elicited against a phosphonate transition state analogue was shown to initiate chemiluminescence from luminogenic spiro[adamantane-2,3′-(1,2-dioxetane)] substrates by selectively cleaving a benzoate ester triggering group.

References

1. Reviews: D. R. Liu and P. G. Schultz, Angew. Chem., Int. Ed., 1999, 38, 36; J.-L. Reymond, Top. Curr. Chem., 1999, 200, 59; G. M. Blackburn, A. Datta, H. Denham and P. Wentworth, Adv. Phys. Org. Chem., 1998, 31, 249; N. R. Thomas, Nat. Prod. Rep., 1996, 13, 479.
2. J. R. Crowther, ELISA Theory & Practice, Humana Press, Totowa, New Jersey, 1995.
3. A synthesis for an alternative hapten and proposed antibody chemiluminescence reaction was reported during the course of this work: M. Sawa, Y. Imaeda, J. Hiratake, R. Fujii, R. Umeshita, M. Watanabe, H. Kondo and J. Oda, Bioorg. Med. Chem. Lett., 1998, 8, 647 However the generaion of an antibody catalyst by these workers has yet to be reported. A catalytic antibody for the luminol-peroxidase reaction has also been reported: L. J. Kricka and X. Ji, Biolumin. Chemilum.: Proc. Int. Symp. 7th 1993, 1993, 518 The authors were not able to demonstrate unequivocally that this activity, which was short-lived, was not due to a contaminating enzyme, or purely a hydrophobic effect.
4. J. A. Smiley and S. J. Benkovic, Proc. Natl. Acad. Sci. U.S.A., 1994, 91, 8319.
5. N. Bensel, N. Bahr, M. T. Reymond, C. Schenkels and J.-L. Reymond, Helv. Chim. Acta, 1999, 82, 44.
6. B. Avalle, S. Vanwetswinkel and J. Fastrez, Bioog. Med. Chem. Lett., 1997, 7, 479; C. F. Barbas, A. Heine, G. F. Zhong, T. Hoffman, S. Gramatikova, R. Bjornestedt, B. List, J. Anderson, E. A. Stura, I. A. Wilson and R. A. Lerner, Science, 1997, 278, 2085.
7. F. Taran, P. Y. Renard, C. Creminon, A. Valleix, Y. Frobert, P. Pradelles, J. Grassi and C. Mioskowski, Tetrahedron Lett., 1999, 40, 1887 1891; G. Macbeath and D. Hilvert, J. Am. Chem. Soc., 1994, 116, 6106; D. S. Tawfik, B. S. Green, R. Chap, M. Sela and Z. Eshhar, Proc. Natl. Acad. Sci. U.S.A., 1993, 90, 373.
8. J.-L. Jestin, P. Kristensen and G. Winter, Angew. Chem., Int. Ed., 1999, 38, 1196; H. Pedersen, S. Hölder, D. P. Sutherlin, U. Schwitter, D. S. King and P. G. Schultz, Proc. Natl. Acad. Sci. U.S.A., 1998, 95, 10 523.
9. L. E. Janes, A. C. Lowendahl and R. J. Kazlauskas, Chem. Eur. J., 1998, 4, 2324.
10. A. P. Schaap, R. S. Handley and B. P. Giri, Tetrahedron Lett., 1987, 28, 935; S. Beck and H. Köster, Anal. Chem., 1990, 62, 2258; A. P. Schaap and H. Akhavan-Tafti, US Patent (U.S.P. WO90/07511) 1990; W. Adam, I. Bronstein, A. V. Tromfimov and R. F. Vasilev, J. Am. Chem. Soc., 1999, 121, 958.
11. G. T. Hermanson, Bioconjugate Techniques, AP, San Diego, 1996, p. 169.
12. R. B. Saishidhar, A. K. Capoor and D. Ramana, J. Immunol. Methods, 1994, 167, 121 An average hapten density of 24 copies of 1 per BSA was found, whilst 49% of the free lysines in the polymeric KLH had been derivatised.
13. E. Harlow and D. Lane, Antibodies: A Laboratory Manual, Cold Spring Harbor, New York, 1988.
14. R. Curci, L. Lopez, L. Troisi, S. M. K. Rashid and A. P. Schaap, Tetrahedron Lett., 1987, 28, 5319.
15. R. E. Kontermann, P. Martineau, C. E. Cummings, A. Karpas, D. Allen, E. Derbyshire and G. Winter, Immunotechnology, 1997, 3, 137.